These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 27906059)

  • 1. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
    Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
    Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Appraisal of the Multifactorial Basis for In Vitro Acquisition of Miltefosine Resistance in Leishmania donovani.
    Vacchina P; Norris-Mullins B; Abengózar MA; Viamontes CG; Sarro J; Stephens MT; Pfrender ME; Rivas L; Morales MA
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4089-100. PubMed ID: 27114280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.
    Pérez-Victoria FJ; Castanys S; Gamarro F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2397-403. PubMed ID: 12878496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes.
    Saint-Pierre-Chazalet M; Ben Brahim M; Le Moyec L; Bories C; Rakotomanga M; Loiseau PM
    J Antimicrob Chemother; 2009 Nov; 64(5):993-1001. PubMed ID: 19749205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes.
    Paris C; Loiseau PM; Bories C; Bréard J
    Antimicrob Agents Chemother; 2004 Mar; 48(3):852-9. PubMed ID: 14982775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).
    Seifert K; Matu S; Javier Pérez-Victoria F; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2003 Oct; 22(4):380-7. PubMed ID: 14522101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.
    Rakotomanga M; Saint-Pierre-Chazalet M; Loiseau PM
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2677-86. PubMed ID: 15980336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes.
    Rakotomanga M; Blanc S; Gaudin K; Chaminade P; Loiseau PM
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1425-30. PubMed ID: 17242145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
    Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes.
    Luque-Ortega JR; Rivas L
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1327-32. PubMed ID: 17283192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
    Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
    Verma NK; Singh G; Dey CS
    Exp Parasitol; 2007 May; 116(1):1-13. PubMed ID: 17161839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani.
    Veronica J; Chandrasekaran S; Dayakar A; Devender M; Prajapati VK; Sundar S; Maurya R
    FEBS J; 2019 Sep; 286(17):3488-3503. PubMed ID: 31087522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.
    Srivastava S; Mishra J; Gupta AK; Singh A; Shankar P; Singh S
    Parasit Vectors; 2017 Jan; 10(1):49. PubMed ID: 28137296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant Leishmania donovani.
    Kulshrestha A; Sharma V; Singh R; Salotra P
    Parasitol Res; 2014 Mar; 113(3):1171-84. PubMed ID: 24449447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites.
    Singh R; Kumar D; Duncan RC; Nakhasi HL; Salotra P
    Int J Antimicrob Agents; 2010 Jul; 36(1):50-7. PubMed ID: 20427152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain.
    Rai K; Cuypers B; Bhattarai NR; Uranw S; Berg M; Ostyn B; Dujardin JC; Rijal S; Vanaerschot M
    mBio; 2013 Oct; 4(5):e00611-13. PubMed ID: 24105765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species.
    Das M; Saudagar P; Sundar S; Dubey VK
    FEBS J; 2013 Oct; 280(19):4807-15. PubMed ID: 23890327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs.
    Rastrojo A; García-Hernández R; Vargas P; Camacho E; Corvo L; Imamura H; Dujardin JC; Castanys S; Aguado B; Gamarro F; Requena JM
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):246-264. PubMed ID: 29689531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.
    Tiwari B; Pahuja R; Kumar P; Rath SK; Gupta KC; Goyal N
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.